Health CanadaGeneral Alert
Important Information About the Risk of Dosing Error for Tamiflu (oseltamivir ph...
Published: October 15, 2009Recall ID: 25432Category: generalCountry: Canada
Product Description & Identification
Important Information About the Risk of Dosing Error for Tamiflu (oseltamivir phosphate) Powder for Oral Suspension (12 mg/mL) - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25432 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/important-information-about-risk-dosing-error-tamiflu-oseltamivir-phosphate-powder |
| Title | Important Information About the Risk of Dosing Error for Tamiflu (oseltamivir phosphate) Powder for Oral Suspension (12 mg/mL) - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2009-10-15 |
| Organization | Marketed health products |